Kainova Therapeutics
PrivateLast Round
Series B
Feb 10, 2026
Total Funding Raised
$72.91M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Kainova Therapeutics is a biopharmaceutical company that develops breakthrough therapies targeting G protein-coupled receptors (GPCRs) for the treatment of immuno-oncology and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kainova Therapeutics Comparables
Compare Kainova Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GPCR Therapeutics | 84% | |
| Confo Therapeutics | 84% | |
| Pathios Therapeutics | 82% | |
Kainova Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 10, 2026 | ||||
| Grant | Jan 25, 2024 | ||||
| Series A | May 10, 2022 | ||||
| Grant | Jan 27, 2022 | ||||
| Debt | Jan 13, 2020 | ||||
VC Round | May 28, 2019 |
Key People
Founding team and executive leadership
Kainova Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Investissement Québec | Series B |
| Idinvest Partners | VC Round |
| CTI Life Sciences Fund | Series B, Series A |
| Alsace Inter Regio Fonds d’Investissement | VC Round |
| Andera Partners | VC Round |
| Agence Nationale de la Recherche | Grant |
| 3B FUTURE Health Fund | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 33% MoM, reaching 1.8K.
- May 17, 2026
Monthly visitors grew 38% MoM, reaching 1.2K.
Kainova Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Kainova Therapeutics's valuation, stock price, and market status.